Breaking News Instant updates and real-time market news.

UNVR

Univar

$22.41

0.18 (0.81%)

, BAYRY

Bayer

$0.00

(0.00%)

16:47
04/04/19
04/04
16:47
04/04/19
16:47

Univar's NexusAg to distribute Novozymes products in Canada

Univar (UNVR) announced that Novozymes has chosen Univar Solutions' NexusAg as the sole distributor for its downstream BioYield enhancers in Canada, which represents a significant portion of the biological products portfolio. The agreement will go into effect at the end of June 2019 and does not cover JumpStart XL and BioRise offerings, which will remain with Bayer (BAYRY). Univar Solutions' NexusAg will provide a dedicated sales presence that is focused on bringing superior market intelligence data and analytics to predict trends and drive growth.

UNVR

Univar

$22.41

0.18 (0.81%)

BAYRY

Bayer

$0.00

(0.00%)

  • 08

    Apr

  • 07

    May

UNVR Univar
$22.41

0.18 (0.81%)

11/07/18
WELS
11/07/18
NO CHANGE
Target $27
WELS
Outperform
Univar price target lowered to $27 from $40 at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic lowered her price target for Univar to $27 from $40 on increased headwinds from FX, Canada, and Global "softness." The analyst reiterates an Outperform rating on the shares.
11/27/18
JEFF
11/27/18
NO CHANGE
Target $28
JEFF
Buy
Jefferies lays out case for Univar shares doubling by end of 2020
Jefferies analyst Laurence Alexander estimates the combined Univar (UNVR) and Nexeo Solutions (NXEO) could achieve $2.70 of earnings per share by 2021 even in a "choppy" environment, with $5.65 per share of cumulative free cash flow over the next two years. A double in the share price by the end of 2020 to $44 per share would hinge on a Plastics divestiture, free cash flow and proceeds deployed to less than three-times net debt to EBITDA, and a stronger conversion ratio, lifting the multiple to 8.5 times EBITDA, 16.1 times earnings and a 6.5% free cash flow yield, Alexander tells investors in a research note. With the deal scheduled to close in the first half of 2019, the analyst does not expect a detailed update on synergies until early 2020. However, he sees "significant" potential upside to estimates and keeps a Buy rating on Univar. The analyst lowered his price target for the stock to $28 from $33.
01/03/19
VERT
01/03/19
UPGRADE
VERT
Buy
Univar upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Kevin McCarthy upgraded Univar (UNVR) to Buy from Hold, citing his view that the deal to combine with Nexeo Solutions (NXEO) amplifies its growth, not its risk.
03/05/19
WELS
03/05/19
NO CHANGE
Target $30
WELS
Outperform
Univar price target raised to $30 from $25 at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic raised her price target for Univar to $30 from $25 following updated guidance. The analyst reiterates an Outperform rating on the shares.
BAYRY Bayer
$0.00

(0.00%)

03/20/19
SBSH
03/20/19
NO CHANGE
SBSH
Bayer shares likely to remain 'depressed' pending trial success, says Citi
While sentiment will "clearly take a knock" at the second Roundup trial going against Bayer (BAYRY), both verdicts were delivered by juries in California and EUR 22B of litigation risk is already priced into the shares, Citi analyst Peter Verdult tells investors in a research note. The analyst says his legal checks continue to instruct him to be more focused on the upcoming Hall vs. Monsanto trial being held in St Louis from April 1. He says that verdict will better determine whether his estimate of a potential settlement liability of $1B-$6B needs to be refined. However, Bayer shares will "likely remain depressed" until there is evidence of the company prevailing in one or more of the six cases to go to trial in 2019, Verdult contends. He keeps a Buy rating on the stock but prefers other Pharma plays AstraZeneca (AZN), Sanofi (SNY), Novartis (NVS) and Merck (MRK).
03/21/19
03/21/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) downgraded to Market Perform from Outperform at Wells Fargo after the company reported the failure of two phase 3 trials for a potential treatment of Alzheimer's disease. 2. Magna (MGA) downgraded to Market Perform from Outperform at BMO Capital with analyst Peter Sklar noting BMW's (BMWYY) lowered 2019 earnings guidance on numerous headwinds reflects how difficult it is for auto manufacturers to grow earnings during a period of flat to declining vehicle production volumes. 3. Munich Re (MURGY) downgraded to Hold from Buy at Jefferies with analyst Philip Kett saying he believes the recent rally leaves less room for valuation upside. 4. Nufarm (NFRMY) downgraded to Neutral from Overweight at JPMorgan with analyst Donald Carducci noting glyphosate is becoming a concern for Bayer (BAYRY) due to a recent U.S. case progressing to phase two. 5. Micron (MU) downgraded to Sell from Neutral at Citi with analyst Christopher Danely saying Micronis trying its best but "you can't swim against a tsunami". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/31/19
DBAB
03/31/19
DOWNGRADE
DBAB
Hold
Bayer downgraded to Hold from Buy at Deutsche Bank
04/01/19
BREN
04/01/19
DOWNGRADE
BREN
Hold
Bayer resumed with a Hold from Buy at Berenberg
Berenberg transferred coverage of Bayer to analyst Sebastian Bray and downgraded the stock to Hold from an under review designation. The analyst sees downside from legal settlements following the unfavorable glyphosate verdicts. He has a price target of EUR 67 for the shares.

TODAY'S FREE FLY STORIES

WMT

Walmart

$103.51

0.45 (0.44%)

05:44
04/25/19
04/25
05:44
04/25/19
05:44
Hot Stocks
UK CMA prohibits merger of Walmart subsidiary Asda with Sainsbury's »

The UK Competition and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    May

  • 16

    May

  • 29

    May

  • 05

    Jun

  • 07

    Jun

  • 13

    Nov

UBS

UBS

$13.16

0.07 (0.53%)

05:41
04/25/19
04/25
05:41
04/25/19
05:41
Hot Stocks
UBS sees higher recurring revenues in Global Wealth Management, Asset Management »

UBS provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

  • 03

    Jun

FB

Facebook

$182.64

-1.13 (-0.61%)

05:38
04/25/19
04/25
05:38
04/25/19
05:38
Recommendations
Facebook price target raised to $215 from $195 at Baird »

Baird analyst Colin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

UBS

UBS

$13.16

0.07 (0.53%)

05:37
04/25/19
04/25
05:37
04/25/19
05:37
Earnings
UBS reports Q1 EPS 30c, consensus 24c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

  • 03

    Jun

PYPL

PayPal

$107.18

0.27 (0.25%)

05:35
04/25/19
04/25
05:35
04/25/19
05:35
Recommendations
PayPal analyst commentary at Baird »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 14

    May

  • 22

    May

  • 03

    Jun

  • 11

    Jun

NOW

ServiceNow

$242.41

-1.085 (-0.45%)

05:32
04/25/19
04/25
05:32
04/25/19
05:32
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

CTXS

Citrix

$100.45

-0.4 (-0.40%)

05:29
04/25/19
04/25
05:29
04/25/19
05:29
Recommendations
Citrix analyst commentary  »

Citrix shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$297.12

1.14 (0.39%)

05:27
04/25/19
04/25
05:27
04/25/19
05:27
Recommendations
Align Technology analyst commentary at Piper Jaffray »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 05

    Jun

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

05:24
04/25/19
04/25
05:24
04/25/19
05:24
Recommendations
Microsoft analyst commentary  »

Jefferies boosts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

IRBT

iRobot

$100.39

-30.03 (-23.03%)

05:21
04/25/19
04/25
05:21
04/25/19
05:21
Recommendations
iRobot analyst commentary at Piper Jaffray »

iRobot needs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    Jul

SWI

SolarWinds

$19.77

0.325 (1.67%)

05:17
04/25/19
04/25
05:17
04/25/19
05:17
Recommendations
SolarWinds analyst commentary at Jefferies »

SolarWinds price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

XLNX

Xilinx

$139.79

2.66 (1.94%)

05:15
04/25/19
04/25
05:15
04/25/19
05:15
Downgrade
Xilinx rating change  »

Xilinx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

SIRI

Sirius XM

$5.71

-0.43 (-7.00%)

05:13
04/25/19
04/25
05:13
04/25/19
05:13
Upgrade
Sirius XM rating change  »

Sirius XM upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

APC

Anadarko

$71.41

7.29 (11.37%)

05:07
04/25/19
04/25
05:07
04/25/19
05:07
Downgrade
Anadarko rating change  »

Anadarko downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 22

    May

CARO

Carolina Financial

$36.91

0.49 (1.35%)

05:06
04/25/19
04/25
05:06
04/25/19
05:06
Earnings
Carolina Financial reports Q1 operating EPS 65c, consensus 69c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

JBAXY

Julius Baer

$0.00

(0.00%)

05:06
04/25/19
04/25
05:06
04/25/19
05:06
Downgrade
Julius Baer rating change  »

Julius Baer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$180.67

-1.66 (-0.91%)

05:04
04/25/19
04/25
05:04
04/25/19
05:04
Upgrade
General Dynamics rating change at JPMorgan »

General Dynamics upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 29

    May

NAVI

Navient

$12.96

0.51 (4.10%)

05:03
04/25/19
04/25
05:03
04/25/19
05:03
Upgrade
Navient rating change  »

Navient upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

PTC

PTC

$101.94

1.12 (1.11%)

05:02
04/25/19
04/25
05:02
04/25/19
05:02
Downgrade
PTC rating change  »

PTC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

04:59
04/25/19
04/25
04:59
04/25/19
04:59
Earnings
Deutsche Bank expects Q1 net income EUR 200M, revenue EUR 6.4B »

For the first quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 29

    Apr

  • 03

    Jun

DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

, CRZBY

Commerzbank

$0.00

(0.00%)

04:57
04/25/19
04/25
04:57
04/25/19
04:57
Hot Stocks
Deutsche Bank ends merger talks with Commerzbank, still reviewing alternatives »

Deutsche Bank (DB)…

DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

CRZBY

Commerzbank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 29

    Apr

  • 03

    Jun

CRZBY

Commerzbank

$0.00

(0.00%)

, DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

04:55
04/25/19
04/25
04:55
04/25/19
04:55
Hot Stocks
Commerzbank announces end of merger talks with Deutsche Bank »

Commerzbank (CRZBY)…

CRZBY

Commerzbank

$0.00

(0.00%)

DB

Deutsche Bank

$8.50

-0.04 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 29

    Apr

  • 03

    Jun

04:55
04/25/19
04/25
04:55
04/25/19
04:55
General news
Breaking General news story  »

Week of 4/20 Jobless…

04:55
04/25/19
04/25
04:55
04/25/19
04:55
General news
Breaking General news story  »

Week of 4/19 EIA Natural…

04:55
04/25/19
04/25
04:55
04/25/19
04:55
General news
Breaking General news story  »

Week of 4/24 Fed Balance…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.